Evolus (EOLS) Change in Receivables (2019 - 2026)

Evolus (EOLS) posted Change in Receivables of -$2.2 million for Q1 2026, down 144.95% on a QoQ basis from $4.8 million in Q4 2025, and down 361.73% year-over-year from $823000.0 in Q1 2025.

Evolus (EOLS) Change in Receivables (2019 - 2026) Analysis & Trends

Evolus' Change in Receivables history runs 8 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

  • Quarterly Change in Receivables fell 361.73% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 48.37% YoY) and the FY2025 annual result came in at $11.5 million, down 41.29% from the prior year.
  • Change in Receivables was -$2.2 million for Q1 2026 at Evolus, down from $4.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $9.5 million in Q2 2024 and bottomed at -$2.2 million in Q1 2026.
  • A 5-year average of $2.8 million and a median of $2.5 million in 2023 frame the typical range for Change in Receivables.
  • Annual changes were most pronounced in 2024 — Change in Receivables jumped 2435.76% — and 2026, when it plunged 361.73%.
  • Evolus' Change in Receivables stood at $1.8 million in 2022, then slumped by 91.44% to $151000.0 in 2023, then soared by 2435.76% to $3.8 million in 2024, then gained by 25.15% to $4.8 million in 2025, then sank by 144.95% to -$2.2 million in 2026.
  • Business Quant data shows EOLS's Change in Receivables at -$2.2 million in Q1 2026, $4.8 million in Q4 2025, and $4.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn -2.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.15 Mn
Mar 31, 2026 -2.15 Mn
Dec 31, 2025 4.79 Mn
Dec 31, 2025 4.79 Mn
Sep 30, 2025 4.94 Mn
Sep 30, 2025 4.94 Mn
Jun 30, 2025 958,000.00
Jun 30, 2025 958,000.00
Mar 31, 2025 823,000.00
Mar 31, 2025 823,000.00
Dec 31, 2024 3.83 Mn
Dec 31, 2024 3.83 Mn
Sep 30, 2024 2.38 Mn
Sep 30, 2024 2.38 Mn
Jun 30, 2024 9.49 Mn
Jun 30, 2024 9.49 Mn
Mar 31, 2024 3.90 Mn
Mar 31, 2024 3.90 Mn
Dec 31, 2023 151,000.00
Dec 31, 2023 151,000.00